Cargando…

Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling

Acute lung injury (ALI) is a critical illness with no current effective treatment. Caveolin-1 indirectly activates inflammation-associated signaling pathways by inhibiting endothelial nitric oxide synthase (eNOS). This induces an imbalance between pro- and anti-inflammatory cytokine levels, which ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Li-Ying, Cai, Wan-Ru, Ma, Chun-Fang, Shou, Qi-Yang, Qian, Jing-Li, Huseyin, Turan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827893/
https://www.ncbi.nlm.nih.gov/pubmed/29599805
http://dx.doi.org/10.1155/2018/2373609
_version_ 1783302545394892800
author Xu, Li-Ying
Cai, Wan-Ru
Ma, Chun-Fang
Shou, Qi-Yang
Qian, Jing-Li
Huseyin, Turan S.
author_facet Xu, Li-Ying
Cai, Wan-Ru
Ma, Chun-Fang
Shou, Qi-Yang
Qian, Jing-Li
Huseyin, Turan S.
author_sort Xu, Li-Ying
collection PubMed
description Acute lung injury (ALI) is a critical illness with no current effective treatment. Caveolin-1 indirectly activates inflammation-associated signaling pathways by inhibiting endothelial nitric oxide synthase (eNOS). This induces an imbalance between pro- and anti-inflammatory cytokine levels, which are involved in the pathogenesis of ALI. The compound Chinese prescription Qi-Dong-Huo-Xue-Yin (QDHXY) is efficacious for ALI treatment via an anti-inflammatory effect; however, the exact underlying mechanism is unknown. Therefore, we explored the protective effect of QDHXY against lipopolysaccharide- (LPS-) induced ALI in mice. Histopathological changes in mouse lung tissues were studied. Furthermore, alterations in the serum levels of pro- and anti-inflammatory cytokines were investigated. The levels of tumor necrosis factor- (TNF-)α, interleukin- (IL-) 6, IL-1β, and interferon-γ-induced protein 10 in bronchoalveolar lavage fluid were measured. Additionally, the expression levels of myeloid differentiation factor 88 (MyD88), caveolin-1, and eNOS were assessed. QDHXY significantly reduced lung infiltration with inflammatory cells and the production of serum pro- and anti-inflammatory cytokines and inhibited the expression of TNF-α, IL-1β, caveolin-1, and MyD88 but not eNOS. These indicate that QDHXY significantly improved the balance between pro- and anti-inflammatory cytokine levels, possibly by inhibiting the caveolin-1 signaling pathway. Therefore, QDHXY may be a potential treatment for ALI.
format Online
Article
Text
id pubmed-5827893
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-58278932018-03-29 Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling Xu, Li-Ying Cai, Wan-Ru Ma, Chun-Fang Shou, Qi-Yang Qian, Jing-Li Huseyin, Turan S. Evid Based Complement Alternat Med Research Article Acute lung injury (ALI) is a critical illness with no current effective treatment. Caveolin-1 indirectly activates inflammation-associated signaling pathways by inhibiting endothelial nitric oxide synthase (eNOS). This induces an imbalance between pro- and anti-inflammatory cytokine levels, which are involved in the pathogenesis of ALI. The compound Chinese prescription Qi-Dong-Huo-Xue-Yin (QDHXY) is efficacious for ALI treatment via an anti-inflammatory effect; however, the exact underlying mechanism is unknown. Therefore, we explored the protective effect of QDHXY against lipopolysaccharide- (LPS-) induced ALI in mice. Histopathological changes in mouse lung tissues were studied. Furthermore, alterations in the serum levels of pro- and anti-inflammatory cytokines were investigated. The levels of tumor necrosis factor- (TNF-)α, interleukin- (IL-) 6, IL-1β, and interferon-γ-induced protein 10 in bronchoalveolar lavage fluid were measured. Additionally, the expression levels of myeloid differentiation factor 88 (MyD88), caveolin-1, and eNOS were assessed. QDHXY significantly reduced lung infiltration with inflammatory cells and the production of serum pro- and anti-inflammatory cytokines and inhibited the expression of TNF-α, IL-1β, caveolin-1, and MyD88 but not eNOS. These indicate that QDHXY significantly improved the balance between pro- and anti-inflammatory cytokine levels, possibly by inhibiting the caveolin-1 signaling pathway. Therefore, QDHXY may be a potential treatment for ALI. Hindawi 2018-02-11 /pmc/articles/PMC5827893/ /pubmed/29599805 http://dx.doi.org/10.1155/2018/2373609 Text en Copyright © 2018 Li-Ying Xu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xu, Li-Ying
Cai, Wan-Ru
Ma, Chun-Fang
Shou, Qi-Yang
Qian, Jing-Li
Huseyin, Turan S.
Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling
title Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling
title_full Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling
title_fullStr Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling
title_full_unstemmed Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling
title_short Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling
title_sort qi-dong-huo-xue-yin inhibits inflammation in acute lung injury in mice via toll-like receptor 4/caveolin-1 signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827893/
https://www.ncbi.nlm.nih.gov/pubmed/29599805
http://dx.doi.org/10.1155/2018/2373609
work_keys_str_mv AT xuliying qidonghuoxueyininhibitsinflammationinacutelunginjuryinmiceviatolllikereceptor4caveolin1signaling
AT caiwanru qidonghuoxueyininhibitsinflammationinacutelunginjuryinmiceviatolllikereceptor4caveolin1signaling
AT machunfang qidonghuoxueyininhibitsinflammationinacutelunginjuryinmiceviatolllikereceptor4caveolin1signaling
AT shouqiyang qidonghuoxueyininhibitsinflammationinacutelunginjuryinmiceviatolllikereceptor4caveolin1signaling
AT qianjingli qidonghuoxueyininhibitsinflammationinacutelunginjuryinmiceviatolllikereceptor4caveolin1signaling
AT huseyinturans qidonghuoxueyininhibitsinflammationinacutelunginjuryinmiceviatolllikereceptor4caveolin1signaling